SCHEMBL14140989

SCHEMBL14140989

CCCCO[C@@H]1C(C)O[C@@H](c2ccc3c(N(C)C)ncnn23)[C@]1(C)OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14038378 0.88 POLRMT (0.31) —
SCHEMBL13532237 0.88 — —
SCHEMBL12305478 0.78 — —
SCHEMBL11924463 0.76 DOT1L (0.30) —
SCHEMBL14140990 0.75 — —
SCHEMBL13531949 0.70 HTR1A (0.31) —
SCHEMBL12306914 0.66 — —
SCHEMBL10100358 0.66 ADORA2A (0.37) —
SCHEMBL13531951 0.66 ADORA2A (0.37) —
SCHEMBL10100412 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008089105-A2 ANTIVIRAL NUCLEOSIDE ANALOGS BIOCRYST PHARMACEUTICALS, INC. (US) 2008-07-24 — — WO disclosed
Send feedback